Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Xeomin for Forehead and Glabellar Wrinkles
NCT02019004Phase 1Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Nov 2013
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in Wrinkles (2 arms), sponsored by Northwestern University. Primary endpoints: Change in glabellar wrinkle score at 6 months and Change in forehead wrinkle score at 6 months. Started Nov 2013; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Wrinkles
Beyond the preview
Go deeper on NCT02019004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019004.